Zhihua Kang

1.1k total citations
34 papers, 782 citations indexed

About

Zhihua Kang is a scholar working on Molecular Biology, Dermatology and Genetics. According to data from OpenAlex, Zhihua Kang has authored 34 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Dermatology and 7 papers in Genetics. Recurrent topics in Zhihua Kang's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Hedgehog Signaling Pathway Studies (6 papers) and Cancer and Skin Lesions (6 papers). Zhihua Kang is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers), Hedgehog Signaling Pathway Studies (6 papers) and Cancer and Skin Lesions (6 papers). Zhihua Kang collaborates with scholars based in China, United States and Sweden. Zhihua Kang's co-authors include Ming Guan, Xinju Zhang, Zhiyuan Wu, Xiao Xu, Bing Xia, Tzeh Keong Foo, Zhiyuan Shen, Shibao Li, Pan Fu and Feng Xu and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Zhihua Kang

33 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhihua Kang China 16 372 168 141 123 116 34 782
A. Amantea Italy 19 311 0.8× 504 3.0× 236 1.7× 77 0.6× 230 2.0× 61 1.2k
Alexandre Nakao Odashiro Canada 15 146 0.4× 77 0.5× 94 0.7× 78 0.6× 158 1.4× 61 670
Antigoni Triantafyllopoulou United States 11 254 0.7× 67 0.4× 90 0.6× 139 1.1× 188 1.6× 19 911
Y. Mérot Switzerland 17 239 0.6× 325 1.9× 132 0.9× 110 0.9× 239 2.1× 51 914
Irene Dougherty United States 12 179 0.5× 158 0.9× 104 0.7× 34 0.3× 74 0.6× 18 757
Su Jin Hwang South Korea 20 411 1.1× 45 0.3× 73 0.5× 13 0.1× 75 0.6× 33 858
K Konrad Austria 18 201 0.5× 317 1.9× 118 0.8× 193 1.6× 145 1.3× 64 1.1k
Kyriaki Aroni Greece 13 87 0.2× 245 1.5× 91 0.6× 35 0.3× 74 0.6× 26 504

Countries citing papers authored by Zhihua Kang

Since Specialization
Citations

This map shows the geographic impact of Zhihua Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhihua Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhihua Kang more than expected).

Fields of papers citing papers by Zhihua Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhihua Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhihua Kang. The network helps show where Zhihua Kang may publish in the future.

Co-authorship network of co-authors of Zhihua Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhihua Kang. A scholar is included among the top collaborators of Zhihua Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhihua Kang. Zhihua Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Zhihua, Zhenming Fu, Xuejiao Tian, et al.. (2025). The role of PCBP1 in carbon ion-induced ferroptosis and inhibition of lung adenocarcinoma proliferation. Frontiers in Public Health. 12. 1496439–1496439.
2.
Li, Tianming, Shiying Chen, Xiaoying Chen, et al.. (2025). CRISPR-based sensing platform for the Group B streptococcus screening in pregnant women. Analytica Chimica Acta. 1370. 344390–344390. 1 indexed citations
3.
Kang, Zhihua, et al.. (2025). Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery. Frontiers in Immunology. 16. 1584087–1584087. 3 indexed citations
4.
Liu, Dong, et al.. (2023). Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway. Clinica Chimica Acta. 544. 117338–117338. 7 indexed citations
5.
Liu, Dong, Weijia Li, Qianqian Xu, et al.. (2022). A rapid multiplex assay of human malaria parasites by digital PCR. Clinica Chimica Acta. 539. 70–78. 8 indexed citations
6.
Kang, Zhihua, Pan Fu, Allen L. Alcivar, et al.. (2021). BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage. Nature Communications. 12(1). 5966–5966. 55 indexed citations
7.
Hu, Ruiming, Jinzhuo Zhao, Haidong Kan, et al.. (2020). Fine Particulate Matter (PM2.5) upregulates expression of Inflammasome NLRP1 via ROS/NF-κB signaling in HaCaT Cells. International Journal of Medical Sciences. 17(14). 2200–2206. 23 indexed citations
8.
Xu, Xiao, Xiaowei Ma, Xinju Zhang, et al.. (2019). Detection of BRAF V600E mutation in fine-needle aspiration fluid of papillary thyroid carcinoma by droplet digital PCR. Clinica Chimica Acta. 491. 91–96. 15 indexed citations
9.
Wu, Zhiyuan, Ni Fan, Xiao Xu, et al.. (2018). A triplex probe-based TaqMan qPCR assay for Calreticulin type I and II mutation detection. Hematology. 24(1). 26–31. 1 indexed citations
10.
Wang, Hua, Xiao Xu, Qunfeng Zhang, et al.. (2017). A portable microfluidic platform for rapid molecular diagnostic testing of patients with myeloproliferative neoplasms. Scientific Reports. 7(1). 8596–8596. 6 indexed citations
11.
Li, Shibao, Zhiyuan Wu, Ping Ma, et al.. (2017). Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression. Cell Death and Disease. 8(10). e3122–e3122. 37 indexed citations
12.
Kang, Zhihua, Qunfeng Zhang, Tingting Hu, et al.. (2015). Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.. PubMed. 8(10). 13233–40. 43 indexed citations
13.
Li, Shibao, Zhiyuan Wu, Yuming Chen, et al.. (2015). Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer. Tumor Biology. 37(4). 5365–5374. 5 indexed citations
14.
Wang, Hua, Weiwei Liu, Xiao Xu, et al.. (2015). Toward point-of-care testing for JAK2 V617F mutation on a microchip. Journal of Chromatography A. 1410. 28–34. 8 indexed citations
15.
Kang, Zhihua, et al.. (2015). Correlation of KIF3A and OVOL1, but not ACTL9, with atopic dermatitis in Chinese pediatric patients. Gene. 571(2). 249–251. 8 indexed citations
16.
Wu, Zhiyuan, Yunqing Zhang, Xinju Zhang, et al.. (2014). A Multiplex Snapback Primer System for the Enrichment and Detection ofJAK2V617F andMPLW515L/K Mutations in Philadelphia-Negative Myeloproliferative Neoplasms. BioMed Research International. 2014. 1–11. 5 indexed citations
17.
Li, Shibao, et al.. (2014). Perioperative changes in peripheral regulatory B cells of patients with esophageal cancer. Molecular Medicine Reports. 10(3). 1525–1530. 5 indexed citations
18.
Miao, Ying, Zhihua Kang, Fang Xu, et al.. (2013). Association Analysis of the IL2RA Gene with Alopecia Areata in a Chinese Population. Dermatology. 227(4). 299–304. 14 indexed citations
19.
Kang, Zhihua, Feng Xu, Zhiyuan Wu, et al.. (2012). Oncogenic mutations in extramammary Paget's disease and their clinical relevance. International Journal of Cancer. 132(4). 824–831. 33 indexed citations
20.
Zhang, Xinju, Tingting Hu, Zhiyuan Wu, et al.. (2012). The JAK2 46/1 haplotype is a risk factor for myeloproliferative neoplasms in Chinese patients. International Journal of Hematology. 96(5). 611–616. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026